RIM
GSK icon

Redwood Investment Management’s GSK GSK Stock Holding History

Redwood Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,290
Closed -$546K – 191
2019
Q4 		$546K Sell
9,290
-1,352
-13% -$75.2K 0.14% 179
2019
Q3 		$568K Hold
10,642
– – 0.15% 171
2019
Q2 		$532K Buy
10,642
+1,571
+17% +$78.8K 0.15% 173
2019
Q1 		$474K Buy
+9,071
New +$453K 0.2% 91

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Redwood Investment Management's GSK Position: Q1 2020 in Review

Redwood Investment Management sold out of GSK (GSK) in Q1 2020, closing a stake of 9,290 shares — an estimated $546K sold.

Redwood Investment Management first reported a position in GSK in Q1 2019 and held it in 4 quarters. The position peaked at $568K in Q3 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Redwood Investment Management reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Redwood Investment Management sold 9,290 GSK shares in Q1 2020, an estimated $546K.
  • Redwood Investment Management first reported a position in GSK in Q1 2019 and held it in 4 quarters.
  • Redwood Investment Management's GSK position peaked at $568K in Q3 2019.
  • 818 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Redwood Investment Management's 13F filing for Q1 2020, filed 13 May 2020.